Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brent Wood

Showing results (1-10 of 75) with videos related to

Pageof 8
Sort By:
Archives of Pathology & Laboratory Medicine|May 11, 2006
9-color and 10-color flow cytometry in the clinical laboratoryBrent Wood
Cytometry. Part B, Clinical Cytometry|September 7, 2007
2006 Bethesda International Consensus recommendations on the immunophenotypic analysis of hematolymphoid neoplasia by flow cytometry: recommendations for training and education to perform clinical flow cytometryBruce Greig, Teri Oldaker, Michael Warzynski, et al.
Cytometry. Part B, Clinical Cytometry|September 12, 2013
Validation of cell-based fluorescence assays: practice guidelines from the ICSH and ICCS - part I - rationale and aimsBruce H Davis, Brent Wood, Teri Oldaker, et al.
Cytometry|December 24, 2002
Multicenter clinical experience with flow cytometric method for fetomaternal hemorrhage detectionJenn C Chen, Bruce H Davis, Brent Wood, et al.
Journal of Clinical Pathology|May 3, 2025
Fifth edition WHO classification: precursor lymphoid neoplasms, acute leukaemias of mixed or ambiguous lineage, myeloid/lymphoid neoplasms, and histiocytic and dendritic cell neoplasms, including strategies for application <b>in resource-limited settings</b>Prashant Tembhare, Xueyan Chen, John K C Chan, et al.
Cytometry. Part B, Clinical Cytometry|August 6, 2014
Apparent CD19 expression by natural killer cells: a potential confounder for minimal residual disease detection by flow cytometry in B lymphoblastic leukemiaLorinda Soma, David Wu, Xueyan Chen, et al.
Cytometry. Part B, Clinical Cytometry|September 12, 2013
Validation of cell-based fluorescence assays: practice guidelines from the ICSH and ICCS - part V - assay performance criteriaBrent Wood, Dragan Jevremovic, Marie C Béné, et al.
Cytometry. Part B, Clinical Cytometry|July 22, 2014
Apparent CD19 expression by natural killer cells: A potential confounder for minimal residual disease detection by flow cytometry in B lymphoblastic leukemiaLorinda Soma, David Wu, Xueyan Chen, et al.
Cancer|September 20, 2011
Prognostic impact of discordant results from cytogenetics and flow cytometry in patients with acute myeloid leukemia undergoing hematopoietic cell transplantationMin Fang, Barry Storer, Brent Wood, et al.
Experimental Hematology|December 29, 2015
CD44 promotes chemoresistance in T-ALL by increased drug effluxCatherine Hoofd, Xuehai Wang, Sonya Lam, et al.
Pageof 8

Showing results (1-10 of 75) with videos related to

Sort By:
Pageof 8
Archives of Pathology & Laboratory Medicine|May 11, 2006
9-color and 10-color flow cytometry in the clinical laboratoryBrent Wood
Cytometry. Part B, Clinical Cytometry|September 7, 2007
2006 Bethesda International Consensus recommendations on the immunophenotypic analysis of hematolymphoid neoplasia by flow cytometry: recommendations for training and education to perform clinical flow cytometryBruce Greig, Teri Oldaker, Michael Warzynski, et al.
Cytometry. Part B, Clinical Cytometry|September 12, 2013
Validation of cell-based fluorescence assays: practice guidelines from the ICSH and ICCS - part I - rationale and aimsBruce H Davis, Brent Wood, Teri Oldaker, et al.
Cytometry|December 24, 2002
Multicenter clinical experience with flow cytometric method for fetomaternal hemorrhage detectionJenn C Chen, Bruce H Davis, Brent Wood, et al.
Journal of Clinical Pathology|May 3, 2025
Fifth edition WHO classification: precursor lymphoid neoplasms, acute leukaemias of mixed or ambiguous lineage, myeloid/lymphoid neoplasms, and histiocytic and dendritic cell neoplasms, including strategies for application <b>in resource-limited settings</b>Prashant Tembhare, Xueyan Chen, John K C Chan, et al.
Cytometry. Part B, Clinical Cytometry|August 6, 2014
Apparent CD19 expression by natural killer cells: a potential confounder for minimal residual disease detection by flow cytometry in B lymphoblastic leukemiaLorinda Soma, David Wu, Xueyan Chen, et al.
Cytometry. Part B, Clinical Cytometry|September 12, 2013
Validation of cell-based fluorescence assays: practice guidelines from the ICSH and ICCS - part V - assay performance criteriaBrent Wood, Dragan Jevremovic, Marie C Béné, et al.
Cytometry. Part B, Clinical Cytometry|July 22, 2014
Apparent CD19 expression by natural killer cells: A potential confounder for minimal residual disease detection by flow cytometry in B lymphoblastic leukemiaLorinda Soma, David Wu, Xueyan Chen, et al.
Cancer|September 20, 2011
Prognostic impact of discordant results from cytogenetics and flow cytometry in patients with acute myeloid leukemia undergoing hematopoietic cell transplantationMin Fang, Barry Storer, Brent Wood, et al.
Experimental Hematology|December 29, 2015
CD44 promotes chemoresistance in T-ALL by increased drug effluxCatherine Hoofd, Xuehai Wang, Sonya Lam, et al.
Pageof 8